Insider · CIK 0001645512

TETRAULT LYNN A.

Reports to the SEC for 4 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001645512

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-30	ALMSALUMIS INC.A Award	Director	AAward	+3,553 sh	—	—	3,553
2026-06-30	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director	AAward	+15.5K sh	—	—	15,528
2026-06-24	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+3,691 sh	—	—	3,691
2026-06-24	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+2,324 sh	—	—	2,324
2026-06-23	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,712 sh	—	—	11,712
2026-06-23	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,712 sh	—	—	0
2026-06-22	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+37K sh	$28.27	+$1.05M	44,000
2026-06-22	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director	SSale	−37K sh	$100.32	−$3.71M	7,000
2026-06-22	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−37K sh	—	—	0
2026-06-15	NEONEOGENOMICS INCS Sale	Director	SSale	−5,307 sh	$11.10	−$58.9K	86,115
2026-06-09	NEONEOGENOMICS INCS Sale	Director	SSale	−5,307 sh	$11.29	−$59.9K	91,422
2026-06-01	NEONEOGENOMICS INCM Exercise/Conversion	Director	MExercise/Conversion	+23.1K sh	—	—	96,729
2026-06-01	NEONEOGENOMICS INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−23.1K sh	—	—	0
2026-06-01	NEONEOGENOMICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+11.1K sh	—	—	11,069
2026-06-01	NEONEOGENOMICS INC · Restricted Stock UnitA Award	Director	AAward	+16K sh	—	—	15,970
2025-07-30	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Director	AAward	+49.8K sh	—	—	49,800
2025-06-24	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+7,037 sh	—	—	7,037
2025-06-24	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+4,712 sh	—	—	4,712
2025-06-18	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	—	—	7,000
2025-06-18	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	0
2025-06-01	NEONEOGENOMICS INCM Exercise/Conversion	Director	MExercise/Conversion	+12.3K sh	—	—	73,652
2025-06-01	NEONEOGENOMICS INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−12.3K sh	—	—	0
2025-06-01	NEONEOGENOMICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+16.1K sh	—	—	16,107
2025-06-01	NEONEOGENOMICS INC · Restricted Stock UnitA Award	Director	AAward	+23.1K sh	—	—	23,077
2025-05-21	ACELYRIN, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−43.7K sh	—	—	0
2025-05-21	ACELYRIN, Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−90K sh	—	—	0
2025-05-09	NEONEOGENOMICS INCP Purchase	Director	PPurchase	+7,000 sh	$8.14	+$57K	7,000
2024-09-10	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$4.15	+$41.5K	13,000
2024-09-10	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+7,501 sh	$18.99	+$142K	20,501
2024-09-10	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director	SSale	−8,490 sh	$49.05	−$416K	12,011
2024-09-10	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director	SSale	−8,661 sh	$50.20	−$435K	3,350
2024-09-10	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director	SSale	−350 sh	$50.60	−$17.7K	3,000
2024-09-10	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2024-09-10	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,501 sh	—	—	0
2024-09-09	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3,199 sh	$18.99	+$60.7K	6,199
2024-09-09	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director	SSale	−3,199 sh	$50.04	−$160K	3,000
2024-09-09	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,199 sh	—	—	7,501
2024-08-26	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,300 sh	$18.99	+$81.7K	7,300
2024-08-26	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director	SSale	−4,300 sh	$50.01	−$215K	3,000
2024-08-26	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,300 sh	—	—	10,700
2024-08-12	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$4.15	+$41.5K	13,000
2024-08-12	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director	SSale	−9,593 sh	$44.62	−$428K	3,407
2024-08-12	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Director	SSale	−407 sh	$45.37	−$18.5K	3,000
2024-08-12	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	10,000
2024-08-10	NEONEOGENOMICS INCM Exercise/Conversion	Director	MExercise/Conversion	+11.3K sh	—	—	61,398
2024-08-10	NEONEOGENOMICS INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−11.3K sh	—	—	0
2024-06-21	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3,000 sh	—	—	3,000
2024-06-21	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,000 sh	—	—	0
2024-06-18	RYTMRHYTHM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	14,000
2024-06-18	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+4,000 sh	—	—	4,000

Recent filings

Accepted (ET)
Jul 24
TETRAULT LYNN A.0001645512-26-000003
SEC(opens sec.gov)
Jun 254
TETRAULT LYNN A.0001104659-26-077864
SEC(opens sec.gov)
Jun 244
TETRAULT LYNN A.0001104659-26-077305
SEC(opens sec.gov)
Jun 174
TETRAULT LYNN A.0001628280-26-043875
SEC(opens sec.gov)
Jun 114
TETRAULT LYNN A.0001628280-26-042506
SEC(opens sec.gov)
Jun 34
TETRAULT LYNN A.0001628280-26-040578
SEC(opens sec.gov)
Aug 14
TETRAULT LYNN A.0001415889-25-020837
SEC(opens sec.gov)
Jun 264
TETRAULT LYNN A.0001104659-25-063068
SEC(opens sec.gov)
Jun 234
TETRAULT LYNN A.0001104659-25-061704
SEC(opens sec.gov)

Companies

Address

C/O ALUMIS INC. 280 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA, 94080